Supernus Pharmaceuticals | Passivo Circulante



Current Liabilities Alterar Data
Abbott USD 14.16B 745M 2024-12
ANI Pharmaceuticals USD 193.68M 3.75M 2024-12
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 140.77M 14.56M 2024-12
Eisai JPY 381.62B 54.78B 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Indivior 962M 50M 2024-09
Novo Nordisk 208.36B 20.45B 2024-09
Pacira USD 309.92M 3.52M 2024-12
Perrigo USD 1.04B 406.3M 2024-12
Pfizer USD 43B 216M 2024-12
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
United Therapeutics USD 738.1M 135.3M 2024-12
Xeris Pharmaceuticals USD 100.44M 9.43M 2024-12



Supernus Pharmaceuticals Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.